These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21225496

  • 1. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
    Sengul D, Sengul I, Astarci MH, Ustun H, Mocan G.
    Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
    [Abstract] [Full Text] [Related]

  • 2. Differential diagnosis of basal cell carcinoma and benign tumors of cutaneous appendages originating from hair follicles by using CD34.
    Sengul D, Sengul I, Astarci MH, Ustun H, Mocan G.
    Asian Pac J Cancer Prev; 2010; 11(6):1615-9. PubMed ID: 21338206
    [Abstract] [Full Text] [Related]

  • 3. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT, Selim MA, Burchette JL, Madden J, Turner J, Herman C.
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [Abstract] [Full Text] [Related]

  • 4. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K, Krahl D.
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A, Guerrero D, Larrinaga B, Iglesias ME, Arrechea MA, Yanguas JI.
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [Abstract] [Full Text] [Related]

  • 6. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
    Krahl D, Sellheyer K.
    Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples.
    Tebcherani AJ, de Andrade HF, Sotto MN.
    Mod Pathol; 2012 Oct; 25(10):1345-53. PubMed ID: 22684216
    [Abstract] [Full Text] [Related]

  • 8. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
    Leblebici C, Bambul Sığırcı B, Kelten Talu C, Koca SB, Huq GE.
    Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
    [Abstract] [Full Text] [Related]

  • 9. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
    Wagoner J, Keehn C, Morgan MB.
    Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D, Sellheyer K.
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [Abstract] [Full Text] [Related]

  • 11. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH, Van Marion AM, Lohman BG, Thissen MR, Steijlen PM, Nelemans PJ, Kelleners-Smeets NW.
    Eur J Dermatol; 2011 Oct; 21(6):870-3. PubMed ID: 21865121
    [Abstract] [Full Text] [Related]

  • 12. Trichoepithelioma of the vulva: report of a case and review of the literature.
    Heller J, Roche N, Hameed M.
    J Low Genit Tract Dis; 2009 Jul; 13(3):186-7. PubMed ID: 19550218
    [Abstract] [Full Text] [Related]

  • 13. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM, Ravis SM, Perkins SM, Moores WB, Billings SD.
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [Abstract] [Full Text] [Related]

  • 14. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
    Sellheyer K, Nelson P.
    J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S, Mar N, McCalmont TH.
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [Abstract] [Full Text] [Related]

  • 16. Bcl-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation.
    Ramos-Ceballos FI, Pashaei S, Kincannon JM, Morgan MB, Smoller BR.
    J Cutan Pathol; 2008 May; 35(5):477-83. PubMed ID: 18399809
    [Abstract] [Full Text] [Related]

  • 17. Benign ocular adnexal tumours of apocrine, eccrine or hair follicle origin.
    Ozdal PC, Callejo SA, Codère F, Burnier MN.
    Can J Ophthalmol; 2003 Aug; 38(5):357-63. PubMed ID: 12956276
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA, Ahmed RA.
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [Abstract] [Full Text] [Related]

  • 19. Primary cutaneous neuroendocrine carcinoma within a cystic trichoblastoma: a nonfortuitous association?
    Battistella M, Durand L, Jouary T, Peltre B, Cribier B.
    Am J Dermatopathol; 2011 Jun; 33(4):383-7. PubMed ID: 21048490
    [Abstract] [Full Text] [Related]

  • 20. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin.
    Kanitakis J, Bourchany D, Faure M, Claudy A.
    Eur J Dermatol; 1999 Jun; 9(5):363-5. PubMed ID: 10417438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.